Laura Medina

Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial

Jayesh Desai, Guzmán Alonso, Se Hyun Kim et al. · Nature Medicine · 2023 · 122 citations · Full text

Medicine, Oncology, Pharmacology +17

Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients

Begoña Jiménez, José Trigo, Bella Pajares et al. · Oral Oncology · 2012 · 47 citations

Medicine, Oncology, Pharmacotherapy +11

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

Mark N. Stein, Armelle Vinceneux, Debbie Robbrecht et al. · Journal of Clinical Oncology · 2025 · 25 citations · Full text

Medicine, Oncology, Pharmacology +17

Single-Agent Divarasib in Patients With <i>KRAS G12C</i> –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study

Adrian G. Sacher, Wilson H. Miller, Manish R. Patel et al. · Journal of Clinical Oncology · 2025 · 21 citations · Full text

Medicine, Oncology, Pharmacology +16

Cross-sensitivity between taxanes in patients with breast cancer

Alfonso Sánchez‐Muñoz, Begoña Jiménez, A. García-Tapiador et al. · Clinical & Translational Oncology · 2011 · 19 citations

Medicine, Cancer Biology, Oncology +10